Manal Hassan
Overview
Explore the profile of Manal Hassan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
4353
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hashim M, Elfert K, Afifi A, Hassan M, Elkheshen A, Gagneja H, et al.
Proc (Bayl Univ Med Cent)
. 2025 Feb;
38(2):127-134.
PMID: 39989999
Introduction: Bleeding from gastric varices (GV) is more drastic and associated with higher mortality than that from esophageal varices. There are multiple therapeutic approaches for GV bleeding. Although endoscopic cyanoacrylate...
2.
Abdelaal M, Diab M, Farhat M, Javle M, Shehata M, Singer E, et al.
J Gastrointest Oncol
. 2025 Jan;
15(6):2656-2662.
PMID: 39816039
Background: Following tumor resection, imaging recommendation for the follow-up of patients with intrahepatic cholangiocarcinoma (IHCCA) include frequent chest, abdomen and pelvis computed tomography (CT) imaging. The appropriateness of additional imaging...
3.
Chamseddine S, Yavuz B, Mohamed Y, Lee S, Yao J, Hu Z, et al.
J Immunother Precis Oncol
. 2024 Nov;
7(4):255-262.
PMID: 39524465
Introduction: Galectin-3 plays critical roles in the adhesion, proliferation, and differentiation of tumor cells. Recent data have suggested that galectin-3 plays a role in the development of hepatocellular carcinoma (HCC);...
4.
Mohamed Y, Lee S, Demir T, Chamseddine S, Hu Z, Xiao L, et al.
Cancer Biomark
. 2024 Sep;
41(1):83-91.
PMID: 39269823
Background: Circulating tumor DNA (ctDNA) is a promising non-invasive marker for detection, diagnosis, treatment selection, and prognosis of hepatocellular carcinoma (HCC). Objective: This study aimed to examine the utility of...
5.
Hassan M, Zhao Y, Zughaier S
Biosensors (Basel)
. 2024 Aug;
14(8).
PMID: 39194603
Rapid identification of microorganisms with a high sensitivity and selectivity is of great interest in many fields, primarily in clinical diagnosis, environmental monitoring, and the food industry. For over the...
6.
Chamseddine S, LaPelusa M, Carter K, Nguyen V, Mohamed Y, Sakr Y, et al.
J Gastrointest Oncol
. 2024 Jul;
15(3):1324-1330.
PMID: 38989410
Background: Immune checkpoint inhibitors (ICIs), agents that stimulate T-cell function, have become the standard first-line treatment for unresectable hepatocellular carcinoma (HCC). However, they may also cause immune-related adverse events (irAEs),...
7.
Nikzad N, Fuentes D, Roach M, Chowdhury T, Cagley M, Badawy M, et al.
J Hepatocell Carcinoma
. 2024 Mar;
11:595-606.
PMID: 38525156
Background And Aims: Limited methods exist to accurately characterize the risk of malignant progression of liver lesions. Enhancement pattern mapping (EPM) measures voxel-based root mean square deviation (RMSD) of parenchyma...
8.
Chamseddine S, LaPelusa M, Xiao L, Mohamed Y, Lee S, Hu Z, et al.
J Hepatocell Carcinoma
. 2024 Mar;
11:455-461.
PMID: 38463542
Introduction: In this study, we explored the potential of plasma growth hormone (GH) as a prognostic biomarker in patients with advanced HCC treated with durvalumab plus tremelimumab (D+T). Methods: In...
9.
Glynn D, Hassan M, Shastri P
Kans J Med
. 2024 Feb;
16:330-331.
PMID: 38298386
No abstract available.
10.
Hassan M, Shawky M, Gibaly A, Fattouh H, Atef M
Int J Oral Maxillofac Implants
. 2023 Nov;
39(4):546-556.
PMID: 37910833
Purpose: To evaluate the efficacy of using a customized xenograft shell with a 1:1 mixture of particulate xenograft and autogenous bone for the reconstruction of horizontally deficient anterior maxillary alveolar...